Vectivbio Holding Ag Stock Cash And Equivalents
| VECTDelisted Stock | USD 16.85 0.00 0.00% |
VectivBio Holding AG fundamentals help investors to digest information that contributes to VectivBio Holding's financial success or failures. It also enables traders to predict the movement of VectivBio Stock. The fundamental analysis module provides a way to measure VectivBio Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VectivBio Holding stock.
VectivBio |
VectivBio Holding AG Company Cash And Equivalents Analysis
VectivBio Holding's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current VectivBio Holding Cash And Equivalents | 142.14 M |
Most of VectivBio Holding's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VectivBio Holding AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, VectivBio Holding AG has 142.14 M in Cash And Equivalents. This is 82.68% lower than that of the Biotechnology sector and 68.21% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 94.74% higher than that of the company.
VectivBio Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VectivBio Holding's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VectivBio Holding could also be used in its relative valuation, which is a method of valuing VectivBio Holding by comparing valuation metrics of similar companies.VectivBio Holding is currently under evaluation in cash and equivalents category among its peers.
VectivBio Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (2.95) % | |||
| Current Valuation | 846.2 M | |||
| Shares Outstanding | 62.81 M | |||
| Shares Owned By Insiders | 4.50 % | |||
| Shares Owned By Institutions | 83.80 % | |||
| Number Of Shares Shorted | 77.6 K | |||
| Price To Book | 3.62 X | |||
| Price To Sales | 21.08 X | |||
| Revenue | 27.34 M | |||
| Gross Profit | 27.34 M | |||
| EBITDA | (79.85 M) | |||
| Net Income | (93.73 M) | |||
| Cash And Equivalents | 142.14 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 10.46 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 4.69 X | |||
| Book Value Per Share | 3.40 X | |||
| Cash Flow From Operations | (56.26 M) | |||
| Short Ratio | 0.04 X | |||
| Earnings Per Share | (2.10) X | |||
| Target Price | 18.33 | |||
| Number Of Employees | 10 | |||
| Beta | 0.1 | |||
| Market Capitalization | 1.06 B | |||
| Total Asset | 252.6 M | |||
| Retained Earnings | (207.76 M) | |||
| Working Capital | 201.47 M | |||
| Z Score | 59.56 | |||
| Net Asset | 252.6 M |
About VectivBio Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VectivBio Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VectivBio Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VectivBio Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in VectivBio Stock
If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |